Per Lund
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Christine Sers (4 shared papers)Peter Schirmacher (2 shared papers)Reinhold Schäfer (3 shared papers)Wolfgang H. Caselmann (1 shared paper)Felix Geißler (1 shared paper)H. P. Dienes (1 shared paper)Anke Schwendel (1 shared paper)André Rosenthal (1 shared paper)
- Journals
- Oncogene (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)Cancer Letters (1 paper)Mutation research. Fundamental and molecular mechanisms of mutagenesis (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Per Lund
9 papers receiving 452 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 126
- Oncology 153
- Molecular Biology 258
- Immunology 70
- Hepatology 22
Countries citing papers authored by Per Lund
This map shows the geographic impact of Per Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lund more than expected).
Fields of papers citing papers by Per Lund
This network shows the impact of papers produced by Per Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lund. The network helps show where Per Lund may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 66 | |
| 2 | 2007 | 63 | |
| 3 | 2009 | 61 | |
| 4 | 2004 | 59 | |
| 5 | 2001 | 57 | |
| 6 | 2006 | 56 | |
| 7 | 2003 | 39 | |
| 8 | 1998 | 36 | |
| 9 | 2011 | 16 |
About Per Lund
Per Lund is a scholar working on Molecular Biology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 9 papers that have together received 453 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), interferon and immune responses (1 paper), MicroRNA in disease regulation (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Immune cells in cancer (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Cancer Research (126 citations), Oncology (153 citations), Molecular Biology (258 citations), Immunology (70 citations) and Hepatology (22 citations). Per Lund has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Christine Sers, Peter Schirmacher, Reinhold Schäfer, Wolfgang H. Caselmann, Felix Geißler, H. P. Dienes, Anke Schwendel, André Rosenthal, Bernd Hinzmann and Oleg Tchernitsa. Their work appears in journals such as Oncogene, Molecular Cancer Therapeutics, British Journal of Cancer, Cancer Letters and Mutation research. Fundamental and molecular mechanisms of mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.